MiMedx Group Inc (MDXG)

Sector:
HEALTH CARE
Industry:
HEALTH CARE SUPPLIES
SIC:
SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
CEO:
Timothy R. Wright
Employees:
810
1775 W OAK COMMONS COURT, NE, MARIETTA, GA 30062
(770) 651-9100

MiMedx Group, Inc. develops and distributes placental tissue allografts for various sectors of healthcare. Its products include EpiFix, a semi-permeable protective barrier membrane product used for the treatment of chronic wounds, including diabetic foot ulcers, venous leg ulcers and pressure ulcers. The company sells its products through direct sales force and independent sales agents, as well as through independent distributors.

Data derived from most recent annual or quarterly report
Market Cap 333.709 Million Shares Outstanding112.36 Million Avg 30-day Volume 675.793 Thousand
P/E Ratio0.0 Dividend Yield0.0 EPS-0.48
Price to Revenue1.5283 Debt to Equity0.6129 EBITDA-11.933 Million
Price to Book Value0.0 Operating Margin-6.5203 Enterprise Value460 Million
Current Ratio3.528 EPS Growth0.675 Quick Ratio2.966
1 Yr BETA 1.6362 52-week High/Low 8.7 / 2.68 Profit Margin-8.3825
Operating Cash Flow Growth49.2612 Altman Z-Score2.9583 Free Cash Flow to Firm -18.186 Million
Earnings Report2022-11-01
View SEC Filings from MDXG instead.

View recent insider trading info

Funds Holding MDXG (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding MDXG

Download CSV

Active Schedule 13D and 13G filings

Please sign in first

Recent Filings

Events (8k)

  • 8-K: filed on 2022-09-16:
    Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-09-06:
    Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
    Item 7.01: Regulation FD Disclosure
    Item 8.01: Other Events
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-08-02:
    Item 2.02: Results of Operations and Financial Condition
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-06-30:
    Item 7.01: Regulation FD Disclosure
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-06-13:
    Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
    Item 5.07: Submission of Matters to a Vote of Security Holders
  • 8-K: filed on 2022-05-24:
    Item 8.01: Other Events
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-05-10:
    Item 7.01: Regulation FD Disclosure
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-05-03:
    Item 2.02: Results of Operations and Financial Condition
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-04-29:
    Item 7.01: Regulation FD Disclosure
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-03-22:
    Item 7.01: Regulation FD Disclosure
    Item 9.01: Financial Statements and Exhibits
  • Prospectus

    Open Market Buys/Sells Last 60 Days

    Open Market Buys (P)

    none

    Open Market Sells (S)

    48.2 Thousand total shares from 4 transactions

    Exercise Derivative Conversion (M)

    none

    Current/Former Insiders

    Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

    NEWTON TODD INTERIM CEO

    • Officer
    • Director
    325,618 2022-09-15 2

    STEIN ROBERT BENJAMIN PRESIDENT, REGENERATIVE MED.

    • Officer
    278,673 2022-09-12 6

    KASHYAP ROHIT PRESIDENT, WC & SURGICAL

    • Officer
    430,072 2022-08-09 3

    GIULIANI MICHAEL J

    • Director
    94,770 2022-06-10 1

    WRIGHT TIMOTHY R CHIEF EXECUTIVE OFFICER

    • Officer
    • Director
    1,711,324 2022-06-09 4

    HAWKINS WILLIAM A

    • Director
    116,865 2022-06-07 1

    BIERMAN JAMES L

    • Director
    125,618 2022-06-07 1

    BEHRENS M KATHLEEN

    • Director
    125,618 2022-06-07 1

    GARDNER PHYLLIS

    • Director
    81,670 2022-06-07 1

    LAURENCIN CATO T

    • Director
    94,770 2022-06-07 1

    GRAVES MARK SVP & CHIEF COMPLIANCE OFFICER

    • Officer
    133,608 2022-05-09 4

    PHELAN WILLIAM LAWRENCE CHIEF ACCOUNTING OFFICER

    • Officer
    144,640 2022-05-06 3

    TURNER SCOTT M SVP, OPERATIONS & PROCUREMENT

    • Officer
    226,643 2022-05-02 4

    CARLSON PETER M CHIEF FINANCIAL OFFICER

    • Officer
    570,198 2022-04-08 3

    HULSE WILLIAM FRANK IV GENERAL COUNSEL AND CAO

    • Officer
    364,916 2022-04-08 3

    EVANS CHARLES ROBERT

    • Director
    121,357 2020-10-02 0

    KOOB CHARLES E

    • Director
    1,431,525 2020-10-02 0

    YESTON NEIL

    • Director
    126,357 2020-10-02 0

    DEWBERRY J TERRY

    • Director
    156,787 2020-08-05 0

    BARRY RICHARD

    • Director
    3,338,135 2020-08-05 0

    SUTTER MARTIN P

    • Director
    • 10% Owner
    0 2020-07-02 0

    FALCON FUND 2 HOLDING COMPANY, L.P.

    • 10% Owner
    0 2020-07-02 0

    LANDY MARK EVP & CHIEF STRATEGY OFFICER

    • Officer
    379,925 2019-07-25 0

    BLESER JOSEPH G

    • Director
    No longer subject to file 2019-06-20 0

    HACK BRUCE

    • Director
    769,728 2019-06-07 0

    HADEN ALEXANDRA O GENERAL COUNSEL & SECRETARY

    • Officer
    154,504 2019-02-22 0

    BORKOWSKI EDWARD EVP & INTERIM CFO

    • Officer
    191,166 2019-02-21 0

    OKUMUS FUND MANAGEMENT LTD.

    OKUMUS OPPORTUNISTIC VALUE FUND LTD.

    OKUMUS AHMET H

    • 10% Owner
    No longer subject to file 2019-01-22 0

    PAPASAN LARRY W

    • Director
    140,158 2018-12-31 0

    AGUILAR LUIS A

    • Director
    25,333 2018-12-31 0

    COLES DAVID JAMES INTERIM CHEF EXECUTIVE OFFICER

    • Officer
    0 2018-07-02 0

    TAYLOR WILLIAM CHARLES PRESIDENT AND COO

    • Officer
    • Director
    557,057 2018-02-27 0

    PETIT PARKER H CHAIRMAN & CEO

    • Officer
    • Director
    4,647,422 2018-02-22 0

    SENKEN MICHAEL J. CHIEF FINANCIAL OFFICER

    • Officer
    273,530 2018-02-22 0

    MCCAW ROBERTA L GENERAL COUNSEL AND SECRETARY

    • Officer
    193,247 2015-02-18 0

    GORLIN STEVE

    • Director
    898,145 2013-05-16 0

    EICHLER KURT M

    • Director
    663,406 2012-07-27 0

    ROOKE ANDREW K. JR.

    • Director
    0 2011-12-14 0

    KOOB THOMAS J CHIEF SCIENTIFIC OFFICER

    • Officer
    0 2011-03-18 0

    BROWN REBECCAH COVERT

    • EVP, PRODUCT DEVELOPMENT
    0 2010-02-23 0

    MILLER MATTHEW JERGESEN EVP

    • Officer
    0 2009-12-30 0

    CULUMBER MICHAEL J. CHIEF FINANCIAL OFFICER

    • Officer
    115,462 2009-12-29 0

    FOCHT LOUISE

    • SENIOR VICE PRESIDENT
    0 2009-07-31 0

    WALLACE RONALD G.

    • Director
    498,891 2008-04-29 0

    JORDAN HAMILTON

    • Director
    1,700,281 2008-02-08 0

    THOMAS JOHN C CFO & SECRETARY

    • Officer
    5,267,492 2008-02-08 0

    BENNETT RUFUS LEWIS SR PRESIDENT OF SUBSIDIARY

    • Officer
    0 2008-02-08 0

    Insider Transactions Last 60 Days

    Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
    Disposed
    Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days

    NEWTON TODD - Director - Officer INTERIM CEO

    2022-09-19 19:13:10 -0400 2022-09-15 A 200,000 a 325,618 direct -3.5831 -7.4919 0.0 1 -11.7264 5

    STEIN ROBERT BENJAMIN - Officer PRESIDENT, REGENERATIVE MED.

    2022-09-14 20:17:28 -0400 2022-09-13 S 8,329 $3.46 d 278,673 direct -5.2326 -17.4419 0.0 1 -17.4419 6

    STEIN ROBERT BENJAMIN - Officer PRESIDENT, REGENERATIVE MED.

    2022-09-14 20:17:28 -0400 2022-09-12 S 19,000 $3.44 d 287,002 direct -5.2326 -17.4419 0.0 1 -17.4419 6

    STEIN ROBERT BENJAMIN - Officer PRESIDENT, REGENERATIVE MED.

    2022-08-16 18:49:42 -0400 2022-08-12 S 8,503 $4.04 d 306,002 direct -2.8571 -6.9048 -29.7619 0.0 1 -35.4762 28

    KASHYAP ROHIT - Officer PRESIDENT, WC & SURGICAL

    2022-08-11 18:30:53 -0400 2022-08-09 S 12,343 $4.21 d 430,072 direct 0.7246 -5.314 -34.5411 1.9324 3 -34.5411 31

    * -

    Transaction Code Definitions
    Code Definition
    A Grant, award or other acquisition pursuant to Rule 16b-3(d)
    C Conversion of derivative security
    D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
    E Expiration of short derivative position
    F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
    G Bona fide gift
    H Expiration (or cancellation) of long derivative position with value received
    I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
    J Other acquisition or disposition
    L Small acquisition under Rule 16a-6
    M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
    O Exercise of out-of-the-money derivative security
    P Open market or private purchase of non-derivative or derivative security
    S Open market or private sale of non-derivative or derivative security
    U Disposition pursuant to a tender of shares in a change of control transaction
    W Acquisition or disposition by will or the laws of descent and distribution
    X Exercise of in-the-money or at-the-money derivative security
    Z Deposit into or withdrawal from voting trust

    IBR Securities Loan Availability

    Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

    Security Date/Time Rebate Rate Fee Rate Shares Available
    MIMEDX GROUP INC MDXG 2022-10-05 22:15:03 UTC 1.6592 1.4108 6500000
    MIMEDX GROUP INC MDXG 2022-10-05 21:45:03 UTC 1.6592 1.4108 6500000
    MIMEDX GROUP INC MDXG 2022-10-05 21:15:04 UTC 1.6592 1.4108 6500000
    MIMEDX GROUP INC MDXG 2022-10-05 20:45:03 UTC 1.6642 1.4058 6500000
    MIMEDX GROUP INC MDXG 2022-10-05 20:15:04 UTC 1.6642 1.4058 6500000
    MIMEDX GROUP INC MDXG 2022-10-05 19:45:04 UTC 1.6642 1.4058 6500000
    MIMEDX GROUP INC MDXG 2022-10-05 19:15:04 UTC 1.6642 1.4058 6500000
    MIMEDX GROUP INC MDXG 2022-10-05 18:45:03 UTC 1.8903 1.1797 6500000
    MIMEDX GROUP INC MDXG 2022-10-05 18:15:03 UTC 1.8903 1.1797 6500000
    MIMEDX GROUP INC MDXG 2022-10-05 17:45:03 UTC 1.8903 1.1797 6500000
    MIMEDX GROUP INC MDXG 2022-10-05 17:15:03 UTC 1.8903 1.1797 6500000
    MIMEDX GROUP INC MDXG 2022-10-05 16:45:04 UTC 2.0589 1.0111 6500000
    MIMEDX GROUP INC MDXG 2022-10-05 16:15:03 UTC 2.0589 1.0111 6500000
    MIMEDX GROUP INC MDXG 2022-10-05 15:45:03 UTC 2.0589 1.0111 6500000
    MIMEDX GROUP INC MDXG 2022-10-05 15:15:03 UTC 2.0589 1.0111 6500000
    MIMEDX GROUP INC MDXG 2022-10-05 14:45:03 UTC 2.0589 1.0111 6500000
    MIMEDX GROUP INC MDXG 2022-10-05 14:15:03 UTC 2.0589 1.0111 6500000
    MIMEDX GROUP INC MDXG 2022-10-05 13:45:03 UTC 2.1366 0.9334 6500000
    MIMEDX GROUP INC MDXG 2022-10-05 13:15:03 UTC 2.1366 0.9334 6500000
    MIMEDX GROUP INC MDXG 2022-10-05 12:45:03 UTC 2.1366 0.9334 6500000

    Current Active Short Positions

    Holder Issuer Net Short Position Position Date Origin

    No recent transactions

    *** To see all congressional transactions (since 2022) for this stock, please use the congressional transaction search page***

    Elevate your investments